<code id='FF615F8646'></code><style id='FF615F8646'></style>
    • <acronym id='FF615F8646'></acronym>
      <center id='FF615F8646'><center id='FF615F8646'><tfoot id='FF615F8646'></tfoot></center><abbr id='FF615F8646'><dir id='FF615F8646'><tfoot id='FF615F8646'></tfoot><noframes id='FF615F8646'>

    • <optgroup id='FF615F8646'><strike id='FF615F8646'><sup id='FF615F8646'></sup></strike><code id='FF615F8646'></code></optgroup>
        1. <b id='FF615F8646'><label id='FF615F8646'><select id='FF615F8646'><dt id='FF615F8646'><span id='FF615F8646'></span></dt></select></label></b><u id='FF615F8646'></u>
          <i id='FF615F8646'><strike id='FF615F8646'><tt id='FF615F8646'><pre id='FF615F8646'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:412
          Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT
          Adobe

          There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

          Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

          advertisement

          Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later
          'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

          0:45OfficerNickolasWilt,a26-year-oldrookiewhowasshotinthehead,willbedischargedonJuly28,2023,aftermor

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Ventyx halts psoriasis drug development after lackluster trial results

          AdobeSANDIEGO—VentyxBiosciencesreportedonMondaythatitwasendingdevelopmentofanexperimentaldrugfortrea